Canagliflozin CV Benefits Appear to Be Dose-Dependent ...Middle East

A post-hoc analysis of the pivotal CANVAS trial shows those receiving higher dose canagliflozin are more likely to experience the cardiovascular benefits associated with the drug. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Canagliflozin CV Benefits Appear to Be Dose-Dependent )

Also on site :

• Elon Musk hints at new ‘America Party’ as Trump fumes billionaire has ‘lost his mind’ after bitter bromance break-up
• Ukrainian recruitment officer killed in suspected car bombing – media
• One '90s Icon Mistaken for Another in Rare Childhood Photo